Alkermes plc (ALKS) — Stock Score Summary

Alkermes plc (ALKS) has a MoatMap StockRank of 83/100 based on Quality (64/100), Value (25/100), and Momentum (79/100) factor scores. The current signal is STRONG BUY. Alkermes is a specialized biopharma player, but its growth is highly dependent on binary clinical trial outcomes and patent litigation rather than structural macro tailwinds.

Alkermes plc is a global biopharmaceutical company focused on developing innovative medicines for central nervous system (CNS) disorders, including schizophrenia, bipolar disorder, and addiction. The company differentiates itself through its proprietary drug delivery technologies and a pipeline of differentiated psychiatric and neurological products. Its specialized focus and R&D capabilities provide a competitive moat in a challenging therapeutic area.

Key Financial Metrics

Price$43.34
Market Cap$6.7B
P/E (TTM)48.20
P/E (Forward)18.42
Price/Book4.12
Return on Equity9.4%
Return on Invested Capital15.6%
Debt/Equity90.30
Gross Margin87.4%
Operating Margin-0.2%
Revenue Growth28.2%
Free Cash Flow$141M

Alkermes plc operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Ireland).

Frequently Asked Questions

What is Alkermes plc’s (ALKS) StockRank?
MoatMap’s StockRank for Alkermes plc (ALKS) is 83/100, with a Strong Buy signal. It is a composite of Quality (64), Value (25), and Momentum (79) factor ranks across MoatMap’s 19,000+ stock universe.
Does Alkermes plc have an economic moat?
Alkermes plc (ALKS) has a Quality factor score of 64/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Alkermes plc a buy, hold, or sell?
MoatMap’s current signal for Alkermes plc (ALKS) is Strong Buy, based on a StockRank of 83/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Alkermes plc in?
Alkermes plc (ALKS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Ireland).
Browse all ranked stocksALKS deep dive reportAI ChampionsHow we score stocksSense-check another stock